Prevalence and Risk Factors of Poststroke Cognitive Impairment: A Systematic Review and Meta‐Analysis
Public Health Nursing · 2025-03 · 42 (2) · 1047-1059
DOI: 10.1111/phn.13503 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Public Health Nursing, online erschienen am 19.12.2024. Verfasst von Yuxia Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Evidence-Based Nursing Center, Lanzhou University, Lanzhou, China. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Stroke. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 96 Literaturangaben. Gefördert von: The Fund of China Medical Board, National Scientific Research Training Plan of Gansu Provincial Hospital, The Research Funds for the School of Nursing of Lanzhou University.
Abstract (Originalsprache)
Background
Stroke is a common disease that poses a significant threat to human health. Approximately one‐third of stroke patients experience poststroke cognitive impairment (PSCI), which severely impacts their quality of life and survival time. Although the prevalence and risk factors for PSCI have been widely reported, these results have not been synthesized.
Objectives
This systematic review was conducted to explore the prevalence and risk factors of PSCI.
Methods
PubMed, EMBASE, Web of Science, and Cochrane Library were comprehensively searched for studies exploring the prevalence and risk factors of PSCI from inception to July 5, 2022.
Results
A total of 49 articles were included for meta‐analysis. It was found that the combined prevalence of PSCI was 39%–47%. Risk factors for PSCI include female gender, age, education level less than 7 years, atrial fibrillation, diabetes, smoking, drinking, hypertension, coronary artery disease, carotid artery plaque, admission NIHSS score ≥ 5, unemployment, and homocysteine.
Conclusions
This systematic review has revealed a combined prevalence of PSCI is ranging from 39% to 47% and identified several risk factors for PSCI. These findings indicate a high incidence of the condition and underscore the need for increased public awareness. Future investigations should prioritize the identification of PSCI risk factors, providing a theoretical basis for nursing professionals to effectively manage and treat PSCI patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Nursing, Evidence-Based Nursing Center, Lanzhou University, Lanzhou, China.
- First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
- Nursing Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Nursing Department, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
- Department of Nursing, Gansu Provincial Hospital, Lanzhou, China.
ORCID-Profile: Yifang Yang, Lin Han
Förderung
- The Fund of China Medical Board
- National Scientific Research Training Plan of Gansu Provincial Hospital
- The Research Funds for the School of Nursing of Lanzhou University
- Fundamental Research Funds for the Central Universities
- Natural Science Foundation of Gansu Province
- National Natural Science Foundation of China
Zitieren
APA
Ma, Y., Yang, Y., Wang, X., Huang, Y., Nan, J., Feng, J., Yan, F., & Han, L. (2025). Prevalence and Risk Factors of Poststroke Cognitive Impairment: A Systematic Review and Meta‐Analysis. Public Health Nursing, 42(2), 1047-1059. https://doi.org/10.1111/phn.13503
Vancouver
Ma Y, Yang Y, Wang X, Huang Y, Nan J, Feng J, et al. Prevalence and Risk Factors of Poststroke Cognitive Impairment: A Systematic Review and Meta‐Analysis. Public Health Nursing. 2025;42(2):1047-1059. doi:10.1111/phn.13503
BibTeX
@article{Ma2025,
author = {Ma, Yuxia and Yang, Yifang and Wang, Xinyu and Huang, Yanan and Nan, Jinhan and Feng, Juanjuan and Yan, Fanghong and Han, Lin},
title = {Prevalence and Risk Factors of Poststroke Cognitive Impairment: A Systematic Review and Meta‐Analysis},
journal = {Public Health Nursing},
year = {2025},
volume = {42},
number = {2},
pages = {1047--1059},
doi = {10.1111/phn.13503}
}
EUVIMED